A new trading day began on Friday, with Rhythm Pharmaceuticals Inc (NASDAQ: RYTM) stock price down -5.92% from the previous day of trading, before settling in for the closing price of $59.77. RYTM’s price has ranged from $30.90 to $68.58 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 175.40% over the last five years. Meanwhile, its annual earnings per share averaged -36.17%. With a float of $54.58 million, this company’s outstanding shares have now reached $59.43 million.
The firm has a total of 226 workers. Let’s measure their productivity. In terms of profitability, gross margin is 88.28%, operating margin of -235.95%, and the pretax margin is -229.52%.
Rhythm Pharmaceuticals Inc (RYTM) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Rhythm Pharmaceuticals Inc is 10.74%, while institutional ownership is 101.12%. The most recent insider transaction that took place on Nov 11 ’24, was worth 4,434,882. In this transaction EVP, Head of North America of this company sold 66,861 shares at a rate of $66.33, taking the stock ownership to the 972 shares. Before that another transaction happened on Nov 11 ’24, when Company’s Chief Technical Officer sold 13,281 for $66.44, making the entire transaction worth $882,341. This insider now owns 0 shares in total.
Rhythm Pharmaceuticals Inc (RYTM) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -36.17% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -9.00% during the next five years compared to -6.04% drop over the previous five years of trading.
Rhythm Pharmaceuticals Inc (NASDAQ: RYTM) Trading Performance Indicators
Here are Rhythm Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.34. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 28.89.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.34, a number that is poised to hit -0.75 in the next quarter and is forecasted to reach -2.67 in one year’s time.
Technical Analysis of Rhythm Pharmaceuticals Inc (RYTM)
Analysing the last 5-days average volume posted by the [Rhythm Pharmaceuticals Inc, RYTM], we can find that recorded value of 0.71 million was better than the volume posted last year of 0.55 million. As of the previous 9 days, the stock’s Stochastic %D was 46.18%. Additionally, its Average True Range was 3.01.
During the past 100 days, Rhythm Pharmaceuticals Inc’s (RYTM) raw stochastic average was set at 57.59%, which indicates a significant increase from 41.11% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 78.51% in the past 14 days, which was higher than the 51.41% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $52.37, while its 200-day Moving Average is $45.50. Now, the first resistance to watch is $59.02. This is followed by the second major resistance level at $61.81. The third major resistance level sits at $63.41. If the price goes on to break the first support level at $54.63, it is likely to go to the next support level at $53.03. Now, if the price goes above the second support level, the third support stands at $50.24.
Rhythm Pharmaceuticals Inc (NASDAQ: RYTM) Key Stats
With a market capitalization of 3.25 billion, the company has a total of 61,457K Shares Outstanding. Currently, annual sales are 77,430 K while annual income is -184,680 K. The company’s previous quarter sales were 33,250 K while its latest quarter income was -43,640 K.
